LOGIN  |  REGISTER
C4 Therapeutics

Recent Insider Transactions - Sonnet BioTherapeutics (NASDAQ: SONN)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ SONN Sonnet BioTherapeutics
Rao Raghu / director, officer: Interim CEO
07/11/2025
Buy
$0.0001
20,000
$2
22,356
NASDAQ SONN Sonnet BioTherapeutics
MCANDREW STEPHEN J / officer: Chief Business Officer
07/11/2025
Buy
$0.0001
6,000
$1
6,446
NASDAQ SONN Sonnet BioTherapeutics
Griffith Donald J. / director, officer: Chief Financial Officer
07/11/2025
Buy
$0.0001
10,000
$1
10,375
NASDAQ SONN Sonnet BioTherapeutics
McNeill Lori / director
07/11/2025
Buy
$0.0001
4,000
$0
4,394
NASDAQ SONN Sonnet BioTherapeutics
Bhatt Nailesh / director
07/11/2025
Buy
$0.0001
10,000
$1
10,547
NASDAQ SONN Sonnet BioTherapeutics
Kenney Richard T / officer: Chief Medical Officer
07/11/2025
Buy
$0.0001
8,000
$1
9,374
NASDAQ SONN Sonnet BioTherapeutics
Cini John K. / officer: Chief Scientific Officer
07/11/2025
Buy
$0.0001
12,000
$1
14,116
NASDAQ SONN Sonnet BioTherapeutics
Dexter Susan / officer: Chief Technical Officer
07/11/2025
Buy
$0.0001
8,000
$1
9,643